NEU neuren pharmaceuticals limited
Add to My Watchlist 0.80% ! $12.54

Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-67

  1. Epichemist
    629 Posts.
    lightbulb Created with Sketch. 342
    clock Created with Sketch.
    02/04/25
    00:00
    Post #: 78507782

    Elsewhere on this site they say FDA has 30 days to publish the minutes after the meeting so probably then. Meeting should be early April so hopefully early March at the latest.
    NEU Price at posting: $11.35 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NUZ Significant Blood-Brain Barrier Penetration Achieved by NUZ-001
right-arrow Created with Sketch.
NEWS Pilbara Exploration Identifies High-Grade Gold and Antimony Targets
right-arrow Created with Sketch.
NEWS Infill Drilling at La Negra Returns High-Grade Silver with Standout 28m at 507gpt
right-arrow Created with Sketch.
NEWS High-grade monazite-rich mineral sands discovery confirmed at Minta Est
right-arrow Created with Sketch.
DAL Maiden work program to commence for Blue Lagoon Zirconium, Niobium and Rare Earth Project in Greenland
right-arrow Created with Sketch.
STN Excellent Gold Intercepts Demonstrate Robust Apollo Hill Resource
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$12.54 		Change
0.100(0.80%) 		Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.